(Q53600678)

16 May 2018

title

Chronic idiopathic myelofibrosis (CIMF) resulting from a unique 3;9 translocation disrupting the janus kinase 2 (JAK2) gene. (English)

1 reference

16 May 2018

chronic idiopathic myelofibrosis

main subject

0 references

author name string

Hon Fong L Mark

1

1 reference

16 May 2018

Edgar A Sotomayor

2

1 reference

16 May 2018

Marilu Nelson

3

1 reference

16 May 2018

Fernando Chaves

4

1 reference

16 May 2018

Warren G Sanger

5

1 reference

16 May 2018

Zahid Kaleem

6

1 reference

16 May 2018

Samuel K Caughron

7

1 reference

16 May 2018

publication date

7 September 2006

1 reference

16 May 2018

Experimental and Molecular Pathology

published in

1 reference

16 May 2018

volume

81

1 reference

16 May 2018

issue

3

1 reference

16 May 2018

page(s)

217-223

1 reference

16 May 2018

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

A gain-of-function mutation of JAK2 in myeloproliferative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

Localization of the gene encoding the secretin receptor, SCTR, on human chromosome 2q14.1 by fluorescence in situ hybridization and chromosome morphometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

Fluorescent in situ hybridization for identifying cytogenetic abnormalities in inadequate and suboptimal specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

Fluorescence in situ hybridization analysis of single-cell trisomies for determination of clonality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

A variant Klinefelter syndrome patient with an XXY/XX/XY karyotype studied by GTG-banding and fluorescence in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

A multimodal approach in the diagnosis of patients with hematopoietic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

Trisomy 9 in a patient with secondary acute myelogenous leukemia detected by fluorescent in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

Hypotetraploidy in a patient with small cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

Conventional cytogenetics and FISH in the detection of BCR/ABL fusion in chronic myeloid leukemia (CML).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

Oncogene amplification in transforming myelodysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

Discordant detection of monosomy 7 by GTG-banding and FISH in a patient with Shwachman-Diamond syndrome without evidence of myelodysplastic syndrome or acute myelogenous leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

Jak family of kinases in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

Identification of an acquired JAK2 mutation in polycythemia vera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2006.07.004

10.1016/J.YEXMP.2006.07.004

7 January 2021

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018